查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1468401

按癌症类型（非小细胞肺癌 (NSCLC)、小细胞肺癌 (SCLC)）、标记类型（EGFR、EML4-ALK、KRAS、BRAF 等）、最终用户（医院、诊断）分类的肺部标记物市场报告实验室等）和地区2024-2032

Lung Marker Market Report by Cancer Type (Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)), Marker Type (EGFR, EML4-ALK, KRAS, BRAF, and Others), End User (Hospitals, Diagnostic Labs, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球IMARC Group标记市场规模达到4.382亿美元。

一般来说，在肺部介入手术或肺部手术和诊断过程中会使用四种主要类型的肺部标记物，包括EGFR、EML4-ALK、KRAS和BRAF。此外，标记物也用于检测、诊断、预测和监测肿瘤，并据此为患者制定治疗方案。肺部标记仅与一些影像学检查和活检一起用作识别癌症的附加工具。因此，肺部标记物广泛用于医院、门诊外科诊所、专科诊所以及其他一些医疗机构的胸腔镜手术。

肺部标记需求的不断增长可归因于全球空气污染水平不断增加导致胸腔积液、胸膜间皮瘤、胸膜斑块等呼吸系统疾病的高盛行率。除此之外，大量被动吸烟以及肺癌家族史进一步增加了肺癌患者的数量，从而增加了对肺部标记的需求。此外，老年人口激增，加上忙碌的消费者生活方式导致高吸烟率，进一步增加了多种呼吸系统疾病的风险。除此之外，各国政府对肺癌等危及生命的疾病的早期诊断和预处理的医疗支出不断增加，也推动了肺部标记物在全球范围内的使用不断增加。此外，对肺癌诊断和治疗领域多项研发活动的投资不断增加，进一步刺激了对肺部标记的需求。除此之外，医院、手术中心、诊所越来越多地使用肺部标记物及其在治疗目的中的各种应用也刺激了产品需求。

本报告回答的关键问题：

  • 迄今为止，全球肺部标记市场表现如何，未来几年将如何表现？
  • COVID-19 对全球肺部标记市场有何影响？
  • 主要区域市场有哪些？
  • 根据癌症类型分類的市场是怎么样的？
  • 基于标记类型的市场区隔是什么？
  • 基于最终用户的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球肺部标记市场的结构如何？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球肺标记物市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依癌症类型

  • 非小细胞肺癌 (NSCLC)
    • 市场走向
    • 市场预测
  • 小细胞肺癌 (SCLC)
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按标记类型

  • 表皮生长因子受体
    • 市场走向
    • 市场预测
  • EML4-ALK
    • 市场走向
    • 市场预测
  • 克拉斯
    • 市场走向
    • 市场预测
  • 布拉夫
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 诊断实验室
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 智利
    • 秘鲁
    • 其他的
  • 中东和非洲
    • 土耳其
    • 伊朗
    • 其他的

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格指标

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Thermo Fisher Scientific Inc
    • Agilent Technologies, Inc.
    • Beckman Coulter, Inc.
    • Fujirebio Europe NV
    • Hologic, Inc.
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers
    • BioSpace, Inc.
Product Code: SR112024A2063

The global lung marker market size reached US$ 438.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,064.0 Million by 2032, exhibiting a growth rate (CAGR) of 10% during 2024-2032.

Generally, four major types of lung markers, including EGFR, EML4-ALK, KRAS, and BRAF, are used during lung intervention procedures or lung surgeries and diagnosis. Furthermore, the markers are used to detect, diagnose, predict, and monitor the tumor, based on which the treatment is prescribed to the patient. Lung markers are only used as an additional tool to identify cancer along with several imaging tests and biopsy. Owing to this, lung markers are extensively used in thoracoscopic surgeries across hospitals, ambulatory surgical clinics, and specialty clinics, among several other healthcare facilities.

The rising demand for lung markers can be attributed to the high prevalence of respiratory disorders, such as pleural effusion, pleural mesothelioma, pleural plaque, etc., due to the increasing air pollution levels, across the globe. Besides this, the high exposure to passive smoking, along with a family history of lung cancer further drives the number of patients suffering from lung cancer, thereby augmenting the demand for lung markers. Additionally, the surging geriatric population, along with the hectic consumer lifestyles leading to a high smoking rate, further accelerate the risks of several respiratory disorders. Apart from this, the increasing healthcare expenditures by various governments for early diagnosis and pre-treatment of life-threatening diseases, such as lung cancer, are also propelling the rising utilization of lung markers at a global level. Furthermore, rising investments in several research and development activities in the field of lung cancer diagnostics and treatment is further catalyzing the demand for lung markers. In addition to this, the increasing usage of lung markers in hospitals, surgery centers, clinics, and their various applications in therapeutic purposes has also catalyzed the product demand.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global lung marker market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on cancer type, marker type and end user.

Breakup by Cancer Type:

Non-Small Cell Lung Cancer (NSCLC)

Small Cell Lung Cancer (SCLC)

Breakup by Marker Type:

EGFR

EML4-ALK

KRAS

BRAF

Others

Breakup by End User:

Hospitals

Diagnostic Labs

Others

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Argentina

Colombia

Chile

Peru

Others

Middle East and Africa

Turkey

Iran

Others

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Beckman Coulter, Inc., Fujirebio Europe N.V., Hologic, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers, and BioSpace, Inc.

Key Questions Answered in This Report:

  • How has the global lung marker market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global lung marker market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the marker type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global lung marker market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Lung Marker Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact Of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Cancer Type

  • 6.1 Non-Small Cell Lung Cancer (NSCLC)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Small Cell Lung Cancer (SCLC)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Marker Type

  • 7.1 EGFR
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 EML4-ALK
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 KRAS
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 BRAF
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Labs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Germany
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 France
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 United Kingdom
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 Italy
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Spain
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Russia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 China
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 Japan
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 India
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 South Korea
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Australia
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Indonesia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Argentina
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
    • 9.4.4 Colombia
      • 9.4.4.1 Market Trends
      • 9.4.4.2 Market Forecast
    • 9.4.5 Chile
      • 9.4.5.1 Market Trends
      • 9.4.5.2 Market Forecast
    • 9.4.6 Peru
      • 9.4.6.1 Market Trends
      • 9.4.6.2 Market Forecast
    • 9.4.7 Others
      • 9.4.7.1 Market Trends
      • 9.4.7.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Turkey
      • 9.5.1.1 Market Trends
      • 9.5.1.2 Market Forecast
    • 9.5.2 Iran
      • 9.5.2.1 Market Trends
      • 9.5.2.2 Market Forecast
    • 9.5.3 Others
      • 9.5.3.1 Market Trends
      • 9.5.3.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Thermo Fisher Scientific Inc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Agilent Technologies, Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Beckman Coulter, Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Fujirebio Europe N.V.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Hologic, Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 F. Hoffmann-La Roche Ltd
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Siemens Healthineers
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 BioSpace, Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Lung Marker Market: Major Drivers and Challenges
  • Figure 2: Global: Lung Marker Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Lung Marker Market: Breakup by Cancer Type (in %), 2023
  • Figure 4: Global: Lung Marker Market: Breakup by Marker Type (in %), 2023
  • Figure 5: Global: Lung Marker Market: Breakup by End User (in %), 2023
  • Figure 6: Global: Lung Marker Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 8: Global: Lung Marker (NSCLC) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Lung Marker (NSCLC) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Lung Marker (SCLC) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Lung Marker (SCLC) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Lung Marker (EGFR) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Lung Marker (EGFR) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Lung Marker (EML4-ALK) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Lung Marker (EML4-ALK) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Lung Marker (KRAS) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Lung Marker (KRAS) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Lung Marker (BRAF) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Lung Marker (BRAF) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Lung Marker (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Lung Marker (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Lung Marker (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Lung Marker (Diagnostic Labs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Lung Marker (Diagnostic Labs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Lung Marker (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia Pacific: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia Pacific: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Middle East and Africa: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Middle East and Africa: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Turkey: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Turkey: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Iran: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Iran: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Latin America: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Latin America: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Brazil: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Brazil: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Mexico: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Mexico: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Argentina: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Argentina: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Colombia: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Colombia: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Chile: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Chile: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Peru: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Peru: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Others: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Global: Lung Marker Industry: SWOT Analysis
  • Figure 91: Global: Lung Marker Industry: Value Chain Analysis
  • Figure 92: Global: Lung Marker Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Lung Marker Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Lung Marker Market Forecast: Breakup by Cancer Type (in Million US$), 2024-2032
  • Table 3: Global: Lung Marker Market Forecast: Breakup by Marker Type (in Million US$), 2024-2032
  • Table 4: Global: Lung Marker Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 5: Global: Lung Marker Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Lung Marker Market: Competitive Structure
  • Table 7: Global: Lung Marker Market: Key Players